The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find... View more

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.View less

Pharmaceutical Published Insights

Coherent Market Insights Castrate Resistant Prostate Cancer Market

Published Date : Jul 2024

Global castrate resistant prostate cancer market growth is driven by rising prevalence of prostate cancer worldwide. Prostate cancer is one of the commonly occurring cancers among men. According to the data from American Cancer Society in 2020, around 191,930 new case... View more

Coherent Market Insights Lyophilized Drugs Market

Published Date : Jul 2024

The global lyophilized drugs market growth is driven by various advantages associated with lyophilization of drugs such as improved stability, ease of administration, and reduced transportation costs. Lyophilization or freeze-drying helps extend the shelf life of drug... View more

Coherent Market Insights Artificial Intelligence In Ultrasound Imaging Market

Published Date : Jul 2024

Artificial Intelligence (AI) in healthcare is transforming medical imaging with the use of deep learning algorithms. One such application is the use of AI in ultrasound imaging. Ultrasound imaging is a commonly used imaging technique due to its non-invasive and cost-e... View more

Coherent Market Insights Dna Repair Drugs Market

Published Date : Jul 2024

DNA repair drugs aim to improve the ability of cells to identify and repair damaged DNA, which could have applications in treating cancer and other diseases related to genomic instability. DNA in the human body undergoes natural wear and tear from environmental exposu... View more

Coherent Market Insights Infertility Drugs Market

Published Date : Jul 2024

Infertility refers to the inability to conceive a child naturally after a period of regular unprotected sexual intercourse. Globally, infertility is a widely prevalent issue with societal and health implications. Global infertility drugs market growth is driven by inc... View more

Coherent Market Insights Regulatory Affairs Outsourcing Market

Published Date : Jul 2024

Global regulatory affairs outsourcing market growth is driven by increasing complexity of regulatory frameworks. Regulatory requirements have become more stringent across regions necessitating specialized expertise and resources for compliance. Furthermore, drug devel... View more

Coherent Market Insights Epinephrine Market

Published Date : Jul 2024

Global epinephrine market is estimated to be valued at USD 2.91 Bn in 2024, exhibiting a compound annual growth rate (CAGR) of 11.6% from 2024 to 2031.  Epinephrine, also known as adrenaline, is a hormone and medication that is used to treat a number of medical c... View more

Coherent Market Insights Telmisartan Market

Published Date : Jul 2024

Telmisartan is an angiotensin II receptor antagonist that is used primarily in the treatment of hypertension and diabetic nephropathy. It works by selectively blocking the binding of angiotensin II to the AT1 receptors present in vascular smooth muscle and the adrenal... View more

Coherent Market Insights Sterile Injectables Market

Published Date : Jul 2024

Global sterile injectables market growth is driven by rising incidence of chronic diseases along with growing geriatric population worldwide who are more susceptible to such diseases. Sterile injectables are used in therapeutic areas like oncology, autoimmune diseases... View more

Coherent Market Insights Pharmaceutical Excipients Market

Published Date : Jul 2024

Pharmaceutical excipients refer to inert substances used as vehicles or additives in drug formulations and products. These are used to confer additional desired properties, aid in product identification, enhance stability, or improve product appearance. Some common ex... View more

Coherent Market Insights Smoking Cessation And Nicotine De Addiction Products Market

Published Date : Jul 2024

The global market for smoking cessation and nicotine de-addiction products is growing significantly owing to the rising global population of smokers and increasing awareness about health hazards of smoking. Smoking has become a worldwide public health issue and the Wo... View more

Coherent Market Insights Immuno Oncology Drugs Market

Published Date : Jul 2024

Immuno-oncology drugs use the body's immune system to fight cancer, and have demonstrated improved survival rates for various cancer types. These drugs boost the immune response against cancer cells, and thus, improve survival outcomes. Some major immuno-oncology drug... View more

Coherent Market Insights Anti Inflammatory Drugs Market

Published Date : Jul 2024

Anti-inflammatory drugs are medications that reduce inflammation in the body. These are commonly used to treat joint pain, arthritis, and other conditions associated with inflammation and pain. Some of the major classes of anti-inflammatory drugs include non-steroidal... View more

Coherent Market Insights Pet Sitting Market

Published Date : Jul 2024

The pet sitting market has seen substantial growth over the past decade. As more individuals now own pets, particularly dogs and cats, and dual income households have become commonplace, there exists a need for pet care services when owners are away. Pet sitting servi... View more

Coherent Market Insights Metastatic Melanoma Therapeutics Market

Published Date : Jul 2024

Metastatic melanoma is a life-threatening form of skin cancer that occurs due to the spread of melanoma skin cancer to other organs of the body. According to recent studies, over 200,000 new cases of melanoma were reported globally in 2020, making it one of the most c... View more

Coherent Market Insights Animal Intestinal Health Market

Published Date : Jul 2024

The global animal intestinal health market has been witnessing significant growth in the recent years. Intestinal health plays a crucial role in overall animal well-being as it helps in the digestion of food and absorption of nutrients. Rising awareness about the impo... View more

Coherent Market Insights Adult Vaccines Market

Published Date : Jul 2024

Global adult vaccines market growth is driven by increasing investments by governments and private firms in adult vaccination programs. Adult vaccinations have gained popularity as these protect vulnerable groups from serious diseases and infections. Growing awareness... View more

Coherent Market Insights Elderly Nutrition Market

Published Date : Jul 2024

Global elderly nutrition market growth is driven by rising geriatric population worldwide and the associated health issues. Nutrition plays a vital role in ensuring the physical well-being and overall health of the aged people. Poor dietary habits and malnutrition amo... View more

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.